Clinical Effect of Putian Capsule in Treating Endometriosis
RCT
OA: closed
CC0
AI-generated summary
Putian Capsule significantly improved hypermenorrhea and menostaxis in endometriosis patients compared to Tianqi Tongjing Capsule, achieving a higher rate of negative EMAb seroconversion.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
To observe the therapeutic effect of Putian Capsule on dysmenorrhea,hypermenorhea,menostaxis associated with endometriosis, 70 cases of endometriosis were randomly allocated to two groups:the treatment group (Putian Capsule)and the control group (Tianqi Tongjing Capsule). The results showed that the total effective rate of Putian Capsule for dysmenorrhea,hypermenorrhea and menostaxis was 85%, 89.7% and 92% respectively,and the differences were significant except for that of dysmenorrhea as compared with the control group.The rate of EMAb turning to negative was 45.45%,which was higher than that in the control group (P 0.01 ).It is indicated that Putian Capsule possesses a definitive effect on endometriosis.
My notes (saved in your browser only)
Condition tags
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0
· commercial use OK